Pyridine → HCID 136079972, compound

HRID 497403Notes

Reaction equation

HRID 497403 reaction equation
[CH2:1]([O:3][C:4]([C:6]1[C:15]2[C:14]3=[N:16][N:17]([CH2:19][CH2:20]O)[CH:18]=[C:13]3[CH2:12][CH2:11][CH2:10][C:9]=2[NH:8][CH:7]=1)=[O:5])[CH3:2].[N:22]1[CH:27]=[CH:26]C=[CH:24][CH:23]=1.CS(Cl)(=O)=O.C(OC(C1C2C3=NN(CCOS(C)(=O)=O)C=C3CCCC=2NC=1)=O)C.C(NCC)C.C([O-])([O-])=O.[K+].[K+]>C(Cl)Cl.CC#N>[CH2:1]([O:3][C:4]([C:6]1[C:15]2[C:14]3=[N:16][N:17]([CH2:19][CH2:20][N:22]([CH2:27][CH3:26])[CH2:23][CH3:24])[CH:18]=[C:13]3[CH2:12][CH2:11][CH2:10][C:9]=2[NH:8][CH:7]=1)=[O:5])[CH3:2]

Participants

9

Conditions

Temperature
0 °C

Procedure

A solution of 2-(2-Hydroxy-ethyl)-4,5,6,7-tetrahydro-2H-1,2,7-triaza-cyclopenta[e]azulene-9-carboxylic acid ethyl ester (866 mg, 2.99 mmol) in CH2Cl2 (6 mL) at 0° C. under N2 is treated with pyridine (0.73 mL, 8.98 mmol) followed by methanesulfonyl chloride (0.28 mL, 3.59 mmol). The reaction mixture is stirred at 0° C. for 10 min. and at room temperature for 4 h. The reaction mixture is then concentrated in vacuo. The crude 2-(2-methanesulfonyloxy-ethyl)-4,5,6,7-tetrahydro-2H-1,2,7-triaza-cyclopenta[e]azulene-9-carboxylic acid ethyl ester is used without further purification. Electrospray mass spectrum: m/z 366 [M−1]. Step 2: To a solution of 2-(2-methanesulfonyloxy-ethyl)-4,5,6,7-tetrahydro-2H-1,2,7-triaza-cyclopenta[e]azulene-9-carboxylic acid ethyl ester (158 mg, 0.43 mmol) in CH3CN is added excess diethylamine (>3 eq) and excess K2CO3. The reaction mixture is stirred overnight at 83° C. in a sealed tube. The reaction mixture is then extracted with CH2Cl2 and washed with water. The aqueous wash is then extracted twice more with CH2Cl2. The combined extracts are dried over K2CO3 and concentrated. The crude material is purified by flash chromatography on silica gel, affording 107 mg (72%) of 2-(2-diethylamino-ethyl)-4,5,6,7-tetrahydro-2H-1,2,7-triaza-cyclopenta[e]azulene-9-carboxylic acid ethyl ester. Electrospray mass spectrum: m/z 343 [M−1]; 1H NMR (CDCl3, 300 MHz) δ 8.78 (br, 1H), 7.17 (d, J=2.7 Hz, 1H), 7.15 (s, 1H), 4.27 (q, J=7.2 Hz, 2H), 4.12 (t, J=7.2 Hz, 2H), 2.91 (m, 2H), 2.81 (m, 2H), 2.65 (m, 2H), 2.59 (q, J=7.2 Hz, 4H), 1.94 (m, 2H), 1.31 (t, J=7.2 Hz, 3H), 1.02 (t, J=7.2 Hz, 6H). Step 3: To a mixture of 2-amino-1,3,4-thiazole (81 mg, 0.798 mmol) in CH2Cl2 (2 mL) at 0° C. under N2 is added 2.0 M trimethylaluminum in toluene (0.4 mL, 0.798 mmol). The mixture is then stirred at room temperature for 1 hr. To the resulting solution is added a solution of 2-(2-diethylamino-ethyl)-4,5,6,7-tetrahydro-2H-1,2,7-triaza-cyclopenta[e]azulene-9-carboxylic acid ethyl ester (55 mg, 0.16 mmol) in CH2Cl2 (1.0 mL) via cannula, followed by a 0.5 mL rinse. The reaction mixture is then stirred at reflux for 4 h. After cooling, the reaction mixture is quenched by the addition of a small amount of 2.0 M aq NaOH and water. A small amount of MeOH is added, and the resulting mixture is stirred vigorously for 30 min. The mixture is filtered through a pad of Celite, washing with CH2Cl2 containing some (˜5%) MeOH. The filtrate is concentrated, and the residue is purified by preparative thin-layer chromatography (silica gel). Two developments using 20:1 CHCl3—MeOH (+1% triethylamine) affords 53 mg (83%) of 2-(2-diethylamino-ethyl)-4,5,6,7-tetrahydro-2H-1,2,7-triaza-cyclopenta[e]azulene-9-carboxylic acid [1,3,4]thiadiazol-2-ylamide as an off-white solid. Electrospray mass spectrum: m/z 398 [M−1]; 1H NMR (CDCl3, 300 MHz) δ 9.14 (br, 1H), 8.79 (s, 1H), 7.71 (d, J=3.0 Hz, 1H), 7.26 (d, J=0.6 Hz, 1H), 4.37 (m, 2H), 3.06 (m, 2H), 3.00 (m, 2H), 2.79 (m, 2H), 2.61 (q, J=7.2 Hz, 4H), 1.97 (m, 2H), 0.99 (t, J=7.2 Hz, 6H). The solid is dissolved in 3-4 mL of EtOH and treated with ˜3 eq of 1.0 M HCl in Et2O. The solution is stirred for 10 min. and then concentrated to remove most of the EtOH. Methyl tert-butyl ether is added, and the resulting precipitate is granulated and filtered. The solid is washed with Et2O and dried under a stream of N2 to afford 54 mg (77%) of the hydrochloride salt of 2-(2-diethylamino-ethyl)-4,5,6,7-tetrahydro-2H-1,2,7-triaza-cyclopenta[e]azulene-9-carboxylic acid [1,3,4]thiadiazol-2-ylamide. Electrospray mass spectrum: m/z 398 [M−1]; 1H NMR (CD3OD, 300 MHz) δ 11.32 (br, 1H), 9.22 (s, 1H), 7.67 (d, J=3.0 Hz, 1H), 7.64 (s, 1H), 4.71 (m, 2H), 4.02 (m, 2H), 3.37 (q, J=7.2 Hz, 4H), 3.05 (m, 2H), 2.85 (m, 2H), 1.99 (m, 2H), 1.33 (t, J=7.2 Hz, 6H).

Workup

  1. concentrationThe reaction mixture is then concentrated in vacuo
  2. customThe crude 2-(2-methanesulfonyloxy-ethyl)-4,5,6,7-tetrahydro-2H-1,2,7-triaza-cyclopenta[e]azulene-9-carboxylic acid ethyl ester is used without further purification
  3. stirringThe reaction mixture is stirred overnight at 83° C. in a sealed tube
  4. extractionThe reaction mixture is then extracted with CH2Cl2
  5. washwashed with water
  6. washThe aqueous wash
  7. extractionis then extracted twice more with CH2Cl2
  8. dry with materialThe combined extracts are dried over K2CO3
  9. concentrationconcentrated
  10. customThe crude material is purified by flash chromatography on silica gel

Sources & evidence

ORD record
ord-afc13590508949a490d3fb251ed56fe8
Source dataset
uspto-grants-2005_09
Patent number
US06949562B2

Reaction notes

Loading…